Clinical trial
Prospective Multicentre Study to Evaluate the Long-term Performance of Anteverted Femoral Stems in Total Hip Arthroplasty
NCT05460715 is registered in ClinicalTrials.gov with Medacta International SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Multicentre Study to Evaluate the Long-term Performance of Anteverted Femoral Stems in Total Hip Arthroplasty
- Lead sponsor
- Medacta International SA
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 30, 2021
- Completion date
- July 31, 2032
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arthrosis, avascular necrosis of the femoral head, congenital hip dysplasia, rheumatoid polyarthritis, traumatic arthritis